148 related articles for article (PubMed ID: 7946937)
1. The effect of angiotensin-converting enzyme inhibitors on human neutrophil chemotaxis in vitro.
Clapperton M; McMurray J; Fisher AC; Dargie HJ
Br J Clin Pharmacol; 1994 Jul; 38(1):53-6. PubMed ID: 7946937
[TBL] [Abstract][Full Text] [Related]
2. Effect of captopril, enalaprilat and mercaptopropionyl glycine (MPG) on the oxidative activity of human isolated neutrophils.
Clapperton M; Beswick PH; Abdullah I; Dargie HJ; Fisher AC; McMurray J
Br J Clin Pharmacol; 1995 Jul; 40(1):31-5. PubMed ID: 8527265
[TBL] [Abstract][Full Text] [Related]
3. Sulfhydryl compounds, captopril, and MPG inhibit complement-mediated myocardial injury.
Kilgore KS; Homeister JW; Satoh PS; Lucchesi BR
Am J Physiol; 1994 Jan; 266(1 Pt 2):H28-35. PubMed ID: 8304510
[TBL] [Abstract][Full Text] [Related]
4. Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals?
Westlin W; Mullane K
Circulation; 1988 Jun; 77(6 Pt 2):I30-9. PubMed ID: 2836109
[TBL] [Abstract][Full Text] [Related]
5. Evidence for stimulation of neutrophil degranulation by selected angiotensin converting enzyme inhibitors in vitro.
Miselis J; Siminiak T; Wysocki H
J Hum Hypertens; 1994 Aug; 8(8):565-9. PubMed ID: 7990082
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the inhibitory effects of PGE2 and selective EP agonists on chemotaxis of human neutrophils.
Armstrong RA
Br J Pharmacol; 1995 Dec; 116(7):2903-8. PubMed ID: 8680723
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of neutrophil chemotaxis, adhesiveness, phagocytosis, and hexose monophosphate shunt activity by N-(2-mercaptopropionyl)glycine.
Patrone F; Dallegri F; Maggi AM; Rapetto C; Lanzi G
Res Exp Med (Berl); 1981; 178(3):257-62. PubMed ID: 7232873
[TBL] [Abstract][Full Text] [Related]
8. Effects of N-(2-mercaptopropionyl) glycine on neutrophil locomotion.
Patrone F; Dallegri F; Lanzi G; Sacchetti C
Int Arch Allergy Appl Immunol; 1981; 64(3):259-65. PubMed ID: 7216505
[TBL] [Abstract][Full Text] [Related]
9. Tiopronin (2-mercaptopropionylglycine) has chemokinetic and chemotactic properties for polymorphonuclear leukocytes.
Elferink JG; de Koster BM
Immunopharmacology; 1992; 23(2):91-6. PubMed ID: 1601642
[TBL] [Abstract][Full Text] [Related]
10. Protection against postischemic myocardial dysfunction in anesthetized rabbits with scavengers of oxygen-derived free radicals: superoxide dismutase plus catalase, N-2-mercaptopropionyl glycine and captopril.
Koerner JE; Anderson BA; Dage RC
J Cardiovasc Pharmacol; 1991 Feb; 17(2):185-91. PubMed ID: 1709221
[TBL] [Abstract][Full Text] [Related]
11. The direct effects of the angiotensin-converting enzyme inhibitors, zofenoprilat and enalaprilat, on isolated human pancreatic islets.
Lupi R; Del Guerra S; Bugliani M; Boggi U; Mosca F; Torri S; Del Prato S; Marchetti P
Eur J Endocrinol; 2006 Feb; 154(2):355-61. PubMed ID: 16452552
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine by sulfones.
Harvath L; Yancey KB; Katz SI
J Immunol; 1986 Aug; 137(4):1305-11. PubMed ID: 3016092
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the role of nitric oxide and cyclic GMP in both the activation and inhibition of human neutrophils.
Wanikiat P; Woodward DF; Armstrong RA
Br J Pharmacol; 1997 Nov; 122(6):1135-45. PubMed ID: 9401778
[TBL] [Abstract][Full Text] [Related]
14. Leukotoxin and its diol induce neutrophil chemotaxis through signal transduction different from that of fMLP.
Totani Y; Saito Y; Ishizaki T; Sasaki F; Ameshima S; Miyamori I
Eur Respir J; 2000 Jan; 15(1):75-9. PubMed ID: 10678624
[TBL] [Abstract][Full Text] [Related]
15. Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection.
Grover GJ; Sleph PG; Dzwonczyk S; Wang P; Fung W; Tobias D; Cushman DW
J Pharmacol Exp Ther; 1991 Jun; 257(3):919-29. PubMed ID: 1646329
[TBL] [Abstract][Full Text] [Related]
16. Stimulation and inhibition of neutrophil chemotaxis by endothelin-3.
Elferink JG; de Koster BM
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S142-4. PubMed ID: 8587345
[TBL] [Abstract][Full Text] [Related]
17. Sulfhydryl group in angiotensin converting enzyme inhibitors and superoxide radical formation.
Mehta JL; Nicolini FA; Lawson DL
J Cardiovasc Pharmacol; 1990 Nov; 16(5):847-9. PubMed ID: 1703610
[TBL] [Abstract][Full Text] [Related]
18. Captopril and enalaprilat do not scavenge the superoxide anion.
Kukreja RC; Kontos HA; Hess ML
Am J Cardiol; 1990 May; 65(19):24I-27I. PubMed ID: 2159692
[TBL] [Abstract][Full Text] [Related]
19. Free radical scavenging: a potentially beneficial action of thiol-containing angiotensin converting enzyme inhibitors.
Chopra M; McMurray J; Stewart J; Dargie HJ; Smith WE
Biochem Soc Trans; 1990 Dec; 18(6):1184-5. PubMed ID: 2088853
[TBL] [Abstract][Full Text] [Related]
20. Reduction by inhibitors of mono(ADP-ribosyl)transferase of chemotaxis in human neutrophil leucocytes by inhibition of the assembly of filamentous actin.
Allport JR; Donnelly LE; Hayes BP; Murray S; Rendell NB; Ray KP; MacDermot J
Br J Pharmacol; 1996 Jul; 118(5):1111-8. PubMed ID: 8818333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
